Comparison of two doses of recombinant VIIA (rFVIIA) for producing hemostasis during and after surgery in patients with hemophilia A or B and inhibitors and patients with acquired inhibitors.

被引：0
|
作者：
Cooper, HA
Gilchrist, GS
Hoots, WK
Shapiro, A
机构：
[1] UNC HOSP,CHAPEL HILL,NC
[2] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
[3] INDIANA UNIV,INDIANAPOLIS,IN 46204
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2665 / 2665
页数：1
相关论文
共 50 条
  • [31] Anti-fibrinolytic effects of recombinant factor VIIa in plasma from patients with hemophilia a with inhibitors
    Bakhtiari, K.
    Mancuso, M. E.
    Hamulyak, K.
    Santagostino, E.
    Schutgens, R. E. G.
    Kamphuisen, P. W.
    Meijers, J. C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 221 - 221
  • [32] RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) THERAPY FOR INTRACRANIAL HEMORRHAGE IN HEMOPHILIA-A PATIENTS WITH INHIBITORS
    SCHMIDT, ML
    GAMERMAN, S
    SMITH, HE
    SCOTT, JP
    DIMICHELE, DM
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (01) : 36 - 40
  • [33] Trace FVIII Augments Rfviia Induced Thrombin Generation and Improves Hemostasis in Hemophilia A Patients with Inhibitors: A clinical Cohort Study
    Livnat, Tami
    Martinowitz, Uri
    Azar-Avivi, Shirley
    Zivelin, Ariela
    Kenet, Gili
    BLOOD, 2012, 120 (21)
  • [34] Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing for acute bleeds in patients with congenital hemophilia with inhibitors (CHwI): results from the dosing observational study in hemophilia (DOSE)
    Young, G.
    Walsh, C.
    Gruppo, R.
    Cooper, D.
    HAEMOPHILIA, 2010, 16 : 80 - 80
  • [35] Primary prophylaxis with recombinant factor VIIa (rFVIIa) in eleven haemophilia a patients with inhibitors younger than 3 years old
    Lopez Fernandez, F.
    Jimenez Yuste, V
    Altisent, C.
    Garcia Candel, F.
    Sedano, C.
    Prieto, M.
    Cid, A.
    Mingot, E.
    Nunez, R.
    Paloma, M.
    Soto, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 523 - 524
  • [36] Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
    Evic, Danko Milo
    Bilic, Ernest
    Batinic, Danica
    Poropat, Mirjana
    tern-Padovan, Ranka
    Galic, Slobodan
    Turudic, Daniel
    BMC PEDIATRICS, 2014, 14
  • [37] Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
    Danko Milošević
    Ernest Bilić
    Danica Batinić
    Mirjana Poropat
    Ranka Štern-Padovan
    Slobodan Galić
    Daniel Turudić
    BMC Pediatrics, 14
  • [38] Monitoring IgE and IgG subclasses in hemophilia B patients with factor IX (FIX) inhibitors.
    Leitermann, K
    Berntorp, E
    Ewenstein, BM
    Sommer, S
    Thompson, AR
    Rup, BJ
    BLOOD, 1997, 90 (10) : 145 - 145
  • [39] Recombinant Factor VIIa (rFVIIa) Is Safe and Effective When Used to Treat Acute Bleeding Episodes and to Prevent Bleeding During Surgery in Patients with Acquired Hemophilia: Updated Assessment From the Hemostasis and Thrombosis Research Society (HTRS) Registry AH Database
    Ma, Alice D.
    Kessler, Craig M.
    Gut, Robert Z.
    Cooper, David L.
    BLOOD, 2011, 118 (21) : 1447 - 1447
  • [40] PRO-PACT: Retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors
    Young, Guy
    Auerswald, Guenter
    Jimenez-Yuste, Victor
    Lambert, Thierry
    Morfini, Massimo
    Santagostino, Elena
    Blanchette, Victor
    THROMBOSIS RESEARCH, 2012, 130 (06) : 864 - 870
12345